Document Type : Original Article
Authors
1
Master of Clinical Psychology, University of Shahed, Tehran, Iran.
2
Associate Professor of clinical Psychology Department, University of Shahed, Tehran, Iran.
3
Assistant Professor of Clinical Psychology Department, University of Tarbiat Modares, Tehran, Iran.
Abstract
Introduction: Since the 1960s, the Achenbach Experience-Based Assessment System (ASEBA) has been utilized for diagnosing mental disorders. The objective of this study was to evaluate the psychometric properties of the Brief Problem Monitoring Test for Ages 18 to 59 (BPM/18-59) within a non-clinical Iranian sample.
Method: A Persian version was created by translating, retranslating, and obtaining approval for the final version of the translation from the instrument manufacturer. Afterward, the BPM/18-59 form was administered to a sample of 337 undergraduate students from the University of Tehran and Tehran University of Medical Sciences during the 2019-2020 academic year, utilizing a convenience sampling method. Additionally, 58 individuals from the subjects' surroundings completed the "Other" form. To calculate the test-retest coefficient of this tool, a retest was administered to 41 participants from the initial sample after an interval of two weeks. To assess the concurrent validity of this tool, the ASRSI-v I.I, DASS-21, GHQ-28, BSI-53, and AAI questionnaires were utilized. Data analysis was conducted using Pearson correlation, confirmatory factor analysis, and hierarchical regression.
Results: The findings indicate a significant correlation between BPM/18-59 and other tools (P < 0.001); therefore, it demonstrates acceptable levels of concurrent validity. The two-week test-retest reliability and Cronbach's alpha for the BPM/18-59 self-report were 0.70 and 0.85, respectively, while the Cronbach's alpha for bystander reports was 0.72. Additionally, factor analysis demonstrated a good fit for the initial three-factor model.
Discussion and Conclusion: BPM/18-59 demonstrates appropriate psychometric properties for application in research and clinical trials involving Iranian individuals.
Keywords